Baird analysts cited lowered investor expectations for orthopedic end market trends and moderating earnings expectations following its Biomet acquisition. Baird raised its price target to $125 from $110 on Zimmer shares. The stock price is expected to reach $125.80 in the short term.
Zimmer shares sank 4.17 percent during the past week and dropped 0.44 percent in the past month. The 52-week low of the shares is $90.48.
More articles on devices:
K2M sets follow-on offering at $18.75 per share — 5 things to know
Implanet’s JAZZ technology receives intellectual patent protection in Europe
FTC makes second request for additional information on Wright Medical-Tornier merger — 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
